| RS119485088 |
GAN
|
Health Risk |
Pathogenic/Likely pathogenic |
Giant axonal neuropathy 1, Inborn genetic diseases |
| RS119485089 |
GAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS119485090 |
GAN
|
Health Risk |
Pathogenic |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS119485092 |
GAN
|
Health Risk |
Likely pathogenic |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS119485093 |
GAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS119485094 |
GAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS119485095 |
GAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS119486096 |
MINPP1
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS1194865614 |
SERPINE1
|
Health Risk |
Pathogenic |
Congenital plasminogen activator inhibitor type 1 deficiency, Congenital plasminogen activator inhibitor type 1 deficiency |
| RS119488099 |
LGI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, familial temporal lobe |
| RS119488100 |
LGI1
|
Health Risk |
Pathogenic |
Epilepsy, familial temporal lobe |
| RS119489101 |
EFEMP2
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal recessive |
| RS119489102 |
EFEMP2
|
Health Risk |
Likely pathogenic |
Cutis laxa, autosomal recessive |
| RS119489103 |
MAPK8IP1
|
Health Risk |
risk factor |
Diabetes mellitus type 2, susceptibility to |
| RS119489104 |
HOXA2
|
Health Risk |
Pathogenic |
Bilateral microtia-deafness-cleft palate syndrome, Bilateral microtia-deafness-cleft palate syndrome |
| RS119489105 |
MERTK
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 38, Autosomal recessive retinitis pigmentosa |
| RS119490107 |
RAD54B
|
Health Risk |
Pathogenic |
Carcinoma of colon, Carcinoma of colon |
| RS119490108 |
GRHPR
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type II |
| RS1194909078 |
RASA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS119491109 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Sialic acid storage disease, severe infantile type |
| RS119491110 |
SLC17A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Sialic acid storage disease, severe infantile type |
| RS1194929977 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Decreased circulating carnitine concentration |
| RS1194936880 |
FADD
|
Health Risk |
Conflicting classifications of pathogenicity |
FADD-related immunodeficiency, Inborn genetic diseases |
| RS1194942976 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17 |
| RS1194966893 |
ALG13
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 36 |
| RS1194981313 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1194990135 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1194990534 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C |
| RS1195002362 |
MYH14
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1195050131 |
ZMYND10
|
Health Risk |
Likely pathogenic |
ZMYND10-related disorder, ZMYND10-related disorder |
| RS1195064309 |
LIFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Stuve-Wiedemann syndrome, Stuve-Wiedemann syndrome |
| RS1195091149 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Lymphangiomyomatosis |
| RS1195103622 |
TG
|
Health Risk |
Pathogenic |
— |
| RS1195128294 |
NPHP4
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1195128790 |
SPTBN2
|
Health Risk |
Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 14, Autosomal recessive spinocerebellar ataxia 14 |
| RS1195131327 |
BBS4
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1195158694 |
CYP1B1
|
Health Risk |
Likely pathogenic |
Anterior segment dysgenesis 6, CYP1B1-related glaucoma with or without anterior segment dysgenesis |
| RS1195159317 |
KCNQ3
|
Health Risk |
Conflicting classifications of pathogenicity |
Benign neonatal seizures, Seizures |
| RS1195164931 |
COL17A1
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa, junctional 4 |
| RS1195177013 |
ABCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive inherited pseudoxanthoma elasticum, Pseudoxanthoma elasticum |
| RS11952056 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS1195259002 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS1195259425 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1195260459 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS1195263093 |
ZFPM2
|
Health Risk |
Pathogenic |
46, XY sex reversal 9 |
| RS1195276132 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1195283929 |
F8
|
Health Risk |
Likely pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS1195320854 |
EXOC6B
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1195336111 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS1195336213 |
PIKFYVE
|
Health Risk |
Likely pathogenic |
Fleck corneal dystrophy, Fleck corneal dystrophy |
| RS1195341481 |
BBS12
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome |
| RS1195346607 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1195350202 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1195350614 |
SLC45A2
|
Health Risk |
Pathogenic |
— |
| RS1195374954 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS1195376092 |
GRIN2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1195379895 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS1195383216 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1195394908 |
XDH
|
Health Risk |
Likely pathogenic |
Hereditary xanthinuria type 1, Hereditary xanthinuria type 1 |
| RS1195401812 |
MRE11
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia-like disorder, Ataxia-telangiectasia-like disorder |
| RS1195403033 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1195416744 |
DNMT3A
|
Health Risk |
Pathogenic |
EBV-positive nodal T- and NK-cell lymphoma, EBV-positive nodal T- and NK-cell lymphoma |
| RS1195417407 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1195418667 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1195430987 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1195475275 |
RAG1
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1195475569 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1195493908 |
USP9X
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1195505218 |
SLC25A22
|
Health Risk |
Pathogenic |
Early myoclonic encephalopathy, Early myoclonic encephalopathy |
| RS1195513248 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS1195519595 |
ARL6
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 3, Retinitis pigmentosa 55 |
| RS1195522061 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1195530396 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma/paraganglioma syndrome 4, Gastrointestinal stromal tumor |
| RS1195533596 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1195543019 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1195549484 |
HPS6
|
Health Risk |
Pathogenic |
— |
| RS1195572987 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1195580419 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1195592039 |
TRIP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Clark-Baraitser syndrome |
| RS1195594601 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 9 |
| RS1195611781 |
ABCA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pulmonary alveolar proteinosis, Interstitial lung disease due to ABCA3 deficiency |
| RS1195620730 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 1, von Willebrand disease type 1 |
| RS1195642515 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1195644432 |
RTTN
|
Health Risk |
Pathogenic/Likely pathogenic |
RTTN-related disorder, RTTN-related disorder |
| RS1195670739 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1195683882 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1195692356 |
GJB2
|
Health Risk |
Pathogenic |
— |
| RS1195694707 |
ADAMTS18
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1195711941 |
KDM6A
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS1195721615 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1195734631 |
TRPM1
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 1C, Congenital stationary night blindness 1C |
| RS1195734687 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1195745037 |
DNAH5
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1195745791 |
MIB1
|
Health Risk |
Likely pathogenic |
Left ventricular noncompaction 7, Left ventricular noncompaction 7 |
| RS1195746445 |
CA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1195760289 |
PKLR
|
Health Risk |
Pathogenic |
— |
| RS1195779037 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS1195785709 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS1195793509 |
TP53
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Ovarian neoplasm |
| RS1195818093 |
ST3GAL3
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 15 |